• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Dec 9:15:1440314.
doi: 10.3389/fimmu.2024.1440314. eCollection 2024. Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven by an elongation factor 1α promoter with leftward orientation

Yusuke Matsumoto[SUP] #[/SUP][SUP] 1 2 [/SUP], Tomoko Honda[SUP] #[/SUP][SUP] 1 [/SUP], Fumihiko Yasui[SUP] 1 [/SUP], Akinori Endo[SUP] 3 [/SUP], Takahiro Sanada[SUP] 1 [/SUP], Sakiko Toyama[SUP] 1 [/SUP], Asako Takagi[SUP] 1 [/SUP], Tsubasa Munakata[SUP] 1 [/SUP], Risa Kono[SUP] 1 [/SUP], Kenzaburo Yamaji[SUP] 1 [/SUP], Naoki Yamamoto[SUP] 1 [/SUP], Yasushi Saeki[SUP] 3 [/SUP], Michinori Kohara[SUP] 1 [/SUP]



Affiliations
Abstract

Introduction: To analyze the molecular pathogenesis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a small animal model such as mice is needed: human angiotensin converting enzyme 2 (hACE2), the receptor of SARS-CoV-2, needs to be expressed in the respiratory tract of mice.
Methods: We conferred SARS-CoV-2 susceptibility in mice by using an adenoviral vector expressing hACE2 driven by an elongation factor 1α (EF1α) promoter with a leftward orientation.
Results: In this model, severe pneumonia like human COVID-19 was observed in SARS-CoV-2-infected mice, which was confirmed by dramatic infiltration of inflammatory cells in the lung with efficient viral replication. An early circulating strain of SARS-CoV-2 caused the most severe weight loss when compared to SARS-CoV-2 variants such as Alpha, Beta and Gamma, although histopathological findings, viral replication, and cytokine expression characteristics were comparable.
Discussion: We found that a distinct proteome of an early circulating strain infected lung characterized by elevated complement activation and blood coagulation, which were mild in other variants, can contribute to disease severity. Unraveling the specificity of early circulating SARS-CoV-2 strains is important in elucidating the origin of the pandemic.

Keywords: COVID-19; SARS-CoV-2; adenoviral vector; mouse model; proteomics.

 
Back
Top Bottom